We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What is Panitumumab?

Mary McMahon
Updated May 17, 2024
Our promise to you
WiseGeek is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At WiseGeek, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject-matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

Panitumumab is a medication used in the treatment of metastatic cancers of the colon or rectum that have not responded to other cancer therapies. This drug may be offered along with treatment options like radiation and surgery, depending on the specifics of a patient's case. It is administered in a clinical setting under supervision, as there is a risk of serious adverse reactions and a patient may need emergency treatment to address bad responses to the drug. Typically, doses are given every two weeks.

This medication is a monoclonal antibody, as signified by the -mab ending. Panitumumab targets cancers known to express epidermal growth factor receptors. The medication binds to them, interfering with the reactions mediated by those receptors and causing the cancer to stop growing. Damaged cancer cells will be broken down and eliminated by the body.

Patients on panitumumab frequently experience symptoms like light sensitivity, nausea, constipation, and fatigue. Patients can also develop swelling of the extremities, as well as a painful mouth and throat, causing difficulty swallowing. Patients should discuss side effects with their doctors, as some may be warning signs of a problem and others may be manageable, increasing patient comfort. Patients with side effects under control tend to have a better prognosis.

There are two potentially serious concerns with panitumumab therapy. One is a skin reaction, where a rash develops. The skin may become infected and because the patient's immune system is not as strong, the infection can become deep and aggressive. Patients who develop redness, swelling, heat, and other skin problems around the infusion site should report them so treatment can be provided in a timely fashion. Another concern is an infusion reaction, where patients receiving the drug develop difficulty breathing and can stop breathing altogether. If people notice shortness of breath or wheezing while receiving the medication, they should bring it to the attention of a doctor or nurse immediately.

While in treatment with panitumumab, patients will be monitored to see how well the cancer is responding and to evaluate their quality of life. Medical imaging may be needed in addition to blood tests and other diagnostic tools to check on the progress of the treatment. Patients will also be interviewed about side effects, as well as issues like depression. Providing detailed and accurate information to clinical providers is important, as it can allow them to catch issues like dangerous side effects early.

WiseGeek is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Mary McMahon
By Mary McMahon

Ever since she began contributing to the site several years ago, Mary has embraced the exciting challenge of being a WiseGeek researcher and writer. Mary has a liberal arts degree from Goddard College and spends her free time reading, cooking, and exploring the great outdoors.

Discussion Comments
Mary McMahon
Mary McMahon

Ever since she began contributing to the site several years ago, Mary has embraced the exciting challenge of being a...

Learn more
WiseGeek, in your inbox

Our latest articles, guides, and more, delivered daily.

WiseGeek, in your inbox

Our latest articles, guides, and more, delivered daily.